# Improvement Summary v0.3

## Date

2026-07-09

## Purpose

This file records the improvements made after the v0.2 checkpoint review. The focus of this iteration was to reduce false certainty, improve metadata discipline, and deepen the evidence base.

## Improvements completed

### 1. Paper database verification status added

`Paper-Database-v0.1.csv` now includes a `verification_status` column.

Current verification categories:

- `verified_arxiv` — metadata and abstract-level claims verified from arXiv record.
- `needs_reverification` — likely useful but not yet checked in this iteration.
- `metadata_unverified` — candidate record only; should not be used as evidence until verified.

This is important because the previous version mixed verified records and unverified records too casually.

### 2. Unverified records now explicitly marked

P007-P011 no longer pretend to have complete metadata. They are now marked as `TO_VERIFY` or `metadata_unverified` where appropriate.

This reduces the risk of citing unverified papers in the living review.

### 3. P016 full extraction added

Added:

`03-Full-Extraction/P016-FinRobot-Equity-Research-Extraction-v0.1.md`

This strengthens the evidence for the emerging category of **equity research agents**.

### 4. P014 full extraction added

Added:

`03-Full-Extraction/P014-Evaluation-Benchmarking-Suite-Extraction-v0.1.md`

This strengthens the evidence for the transition from model-performance evaluation toward lifecycle evaluation, governance, leaderboards, AgentOps, and documentation.

### 5. Claim-evidence ledger updated

`Claim-Evidence-Ledger-v0.1.csv` was updated with:

- stronger wording for C003 after P016 extraction;
- clearer limits for C004 and C005;
- new claim C007 on lifecycle evaluation and governance;
- new claim C008 on equity research agents as a bridge category.

## What became stronger

### Stronger claim 1

**Investment research agents are a distinct category from trading agents.**

This is now better supported by P016, but still only partially supported. More papers are needed.

### Stronger claim 2

**Financial AI evaluation is moving toward lifecycle evaluation and governance.**

This is now provisionally supported by P014.

### Stronger claim 3

**Equity research agents can bridge finance QA and full investment research systems.**

This is now partially supported by P016 and P013.

## What remains weak

### Weakness 1: P007-P011 metadata

These records remain unresolved and should not be used as evidence until verified.

### Weakness 2: Full extraction is still abstract-level

P001, P013, P014, and P016 now have extraction files, but most are still abstract-level plus methodological interpretation. Full-text section/table/figure extraction remains pending.

### Weakness 3: Search-Round-02 is still not done

A real systematic review still requires a properly logged Search-Round-02 with exact source-level result counts.

### Weakness 4: Claim C006 remains a strategic hypothesis

The claim that the strongest PhD direction is reproducible, auditable, risk-aware multi-agent investment research systems is reasonable, but still a strategic synthesis rather than a proven conclusion.

## Current status after v0.3

Project Aegis remains at approximately:

**Level 1.7 / 5 — stronger structured foundation, still not systematic review.**

It is closer to Level 2, but still needs:

1. clean metadata;
2. reproducible search;
3. full extractions;
4. evidence-backed scoring;
5. quantified PRISMA counts.

## Recommended next step

Start `Search-Round-02` with a strict source-by-source log, or complete full extraction for P004 and P006 if the goal is to strengthen the current core evidence before expanding the database.
